ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells.
Munshi M, Liu X, Kofides A, Tsakmaklis N, Hunter ZR, Guerrera ML, Canning A, Gustine JN, Liu S, Hatcher JM, Chen J, Meid K, Sarosiek S, Flynn CA, Branagan AR, von Keudell G, Palomba LM, Castillo JJ, Yang G, Treon SP.
Munshi M, et al. Among authors: flynn ca.
Br J Haematol. 2024 Nov;205(5):1866-1872. doi: 10.1111/bjh.19756. Epub 2024 Sep 18.
Br J Haematol. 2024.
PMID: 39295138